Journal article

P66shc and its role in ischemic cardiovascular diseases


Authors listBoengler, Kerstin; Bornbaum, Julia; Schlueter, Klaus-Dieter; Schulz, Rainer

Publication year2019

JournalBasic Research in Cardiology

Volume number114

Issue number4

ISSN0300-8428

eISSN1435-1803

DOI Linkhttps://doi.org/10.1007/s00395-019-0738-x

PublisherSpringer


Abstract
Oxidative stress caused by an imbalance in the formation and removal of reactive oxygen species (ROS) plays an important role in the development of several cardiovascular diseases. ROS originate from various cellular origins; however, the highest amount of ROS is produced by mitochondria. One of the proteins contributing to mitochondrial ROS formation is the adaptor protein p66shc, which upon cellular stresses translocates from the cytosol to the mitochondria. In the present review, we focus on the role of p66shc in longevity, in the development of cardiovascular diseases including diabetes, atherosclerosis and its risk factors, myocardial ischemia/reperfusion injury and the protection from it by ischemic preconditioning. Also, the contribution of p66shc towards cerebral pathologies and the potential of the protein as a therapeutic target for the treatment of the aforementioned diseases are discussed.



Citation Styles

Harvard Citation styleBoengler, K., Bornbaum, J., Schlueter, K. and Schulz, R. (2019) P66shc and its role in ischemic cardiovascular diseases, Basic Research in Cardiology, 114(4), Article 29. https://doi.org/10.1007/s00395-019-0738-x

APA Citation styleBoengler, K., Bornbaum, J., Schlueter, K., & Schulz, R. (2019). P66shc and its role in ischemic cardiovascular diseases. Basic Research in Cardiology. 114(4), Article 29. https://doi.org/10.1007/s00395-019-0738-x



Keywords


ADAPTER PROTEINFREE-RADICALSISCHEMIA/REPERFUSION INJURYKINASE-C-BETAp66ShcP66(SHC) LONGEVITY GENEPERIPHERAL-BLOOD MONOCYTESpreconditioningreperfusion

Last updated on 2025-02-04 at 01:03